Does fresh single embryo transfer outcome predict the result of a subsequent vitrified-warmed blastocyst of the same cohort?


Journal

Human fertility (Cambridge, England)
ISSN: 1742-8149
Titre abrégé: Hum Fertil (Camb)
Pays: England
ID NLM: 100888143

Informations de publication

Date de publication:
Apr 2022
Historique:
pubmed: 21 7 2020
medline: 10 6 2022
entrez: 21 7 2020
Statut: ppublish

Résumé

Reflecting the current trends, the utilization of frozen-thawed transfer cycles has been steadily increasing worldwide; outcome predictors of these cycles are therefore a major research goal. Our aim was to investigate whether the outcome of a fresh single blastocyst transfer (SBT) can serve as a prognostic factor for the subsequent vitrified-warmed SBT originating from the same cohort. A retrospective cohort study was performed at a single unit. Non-donor fresh cycles were analyzed as predictors of the following vitrified-warmed cycle. Only SBTs were included. Cycles designated to a freeze-all policy and cycles involving pre-implantation genetic analysis were excluded. A total of 1127 vitrified-warmed single blastocyst cycles were included. The indications for artificial reproductive technologies were comparable across the study groups. Vitrified-warmed cycles following a live birth outcome in the fresh cycle were more likely to result in a clinical pregnancy than those following a fresh cycle, which failed to reach a live birth. The same trend was observed for live birth rate following vitrified-warmed transfer in the fresh cycle. After correcting for possible confounders, age and embryo quality were significantly correlated with the chance for a live birth, but the previous fresh cycle did not affect the results. We therefore conclude that after adjustment for age, embryo quality and number of previous oocyte retrieval cycles, the fresh cycle outcome was not a significant influential factor for the following vitrified-warmed cycle.

Identifiants

pubmed: 32686561
doi: 10.1080/14647273.2020.1794061
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

323-328

Auteurs

Anat Hershko Klement (A)

Department of Obstetrics and Gynecology, IVF Unit, Hadassah Mount Scopus, Jerusalem, Israel.

Togas Tulandi (T)

Obstetrics and Gynecology Department, MUHC Reproductive Center, McGill University, Montreal, Canada.

Joseph Hasson (J)

Obstetrics and Gynecology Department, MUHC Reproductive Center, McGill University, Montreal, Canada.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Samer Tannus (S)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Omer Weitzner (O)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel.

Son Weon-Young (S)

Obstetrics and Gynecology Department, MUHC Reproductive Center, McGill University, Montreal, Canada.

Amir Wiser (A)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel.

Tal Shavit (T)

Obstetrics and Gynecology Department, MUHC Reproductive Center, McGill University, Montreal, Canada.
Department of Gynecology and IVF Unit, Assuta Ramat Hachayal, Tel Aviv-Yafo, Israel.
Department of Obstetrics and Gynecology, Ben-Gurion University, Beer-Sheave, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH